96981 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Hormones
Method for increasing natriuresis or diuresis by isoforms of brain natriuretic peptide
#602Fusion protein of Exendin-4 and its analog, preparation method and use thereof
#603GIP and exendin hybrid polypeptides
#604Process for the synthesis of 37-mer peptide pramlintide
#605Process for the purification of a growth factor protein
#606LONG-ACTING Y2 RECEPTOR AGONISTS
#607THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES
#608Therapeutic agents comprising insulin and elastin-like peptides
#609Methods of treating diabetes using therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptides
#610Compositions and methods for brown fat induction and activity using FNDC5
#611Methods of treating diabetes and compositions capable of same
#612METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER
#613Amylin analogues and pharmaceutical compositions thereof
#614Benzocyanine compounds
#615LONG-ACTING Y2 RECEPTOR AGONISTS
#616Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
#617Chimeric aquaretic and natriuretic polypeptides lacking vasodilatory activity
#618Pharmaceutical preparation comprising recombinant hCG
#619METHODS AND PHARMACEUTICAL COMPOSITION FOR THE PRESERVATION OF VASCULAR ENDOTHELIAL CELL BARRIER INTEGRITY
#620Peptide tyrosine tyrosine analogues
#621METHODS OF PRODUCING HYBRIDOMAS AND MONOCLONAL ANTIBODIES AND ANTIBODIES PRODUCED THEREBY
#622Polypeptides
#623Polypeptides
#624Nucleic acids encoding GAS57 mutant antigens
#625GLP-1, exendin-4, peptide analogs and uses thereof
#626Peptidyl α-hydroxyglycine α-amidating lyases
#627GLP-I Agonist And Cardiovascular Complications
#628Method for making polypeptides
#629DRUG FUSIONS AND CONJUGATES WITH EXTENDED HALF LIFE
#630Tissue protective peptides and uses thereof
#631Pharmaceutical compositions and methods for delivering such compositions
#632Mirac proteins
#633SUSBSTANTIALLY PURE STEROIDOGENESIS INDUCING PEPTIDE AND USES THEREOF
#634Hybrid polypeptides with selectable properties
#635MULLERIAN INHIBITING SUBSTANCE (MIS) ANALOGUES
#636FGF-9 variants and methods for use thereof
#637Method for producing natively folded proteins in a prokaryotic host
#638Methods for treatment using amylin family peptides
#639Carrier immunoglobulins
#640Methods of treatment of heart failure with natriuretic peptides
#641SOGA polynucleotides and polypeptides and uses thereof
#642Peptide and use thereof
#643OXYNTOMODULIN ANALOGS
#644Mirac proteins
#645Gastric Inhibitory Peptide Variants and Their Uses
#646Non-cytotoxic protein conjugates
#647INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#648Modified human interferon polypeptides and their uses
#649Tissue protective peptides and uses thereof
#650Method of treating hypertrophic cardiomyopathy
#651Stable analogs of peptide and polypeptide therapeutics
#652Method of promoting bone growth by an anti-activin A antibody
#653METHODS AND COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
#654SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
#655PEPTIDE DERIVATIVE
#656Labelled adrenomedullin derivatives and their use for imaging and therapy
#657AMYLIN AGONIST COMPOUNDS FOR ESTROGEN-DEFICIENT MAMMALS
#658Fusion proteins
#659Stabilized bioactive peptides and methods of identification, synthesis, and use
#660Method for promoting bone growth using activin-actriia antagonists
#661Albumin fusion proteins
#662Mini-hepcidin peptides and methods of using thereof
#663Method for treating pulmonary hypertension
#664Satiation peptide administration
#665INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#666Compositions and methods for treating kidney disease
#667Method for preparing a site-specific physiologically active polypeptide conjugate
#668PROCESS FOR THE PRODUCTION OF PREFORMED CONJUGATES OF ALBUMIN AND A THERAPEUTIC AGENT
#669PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS
#670Protein Expression Methods
#671Serum albumin binding molecules
#672NEUROMEDIN U RECEPTOR AGONISTS AND USES THEREOF
#673Process for the Preparation of Pramlintide
#674Production of glycoproteins using manganese
#675Long-Acting Y2 and/or Y4 Receptor Agonists
#676Helicobacter system and uses thereof
#677NOVEL POLYPEPTIDES RELATED TO B-TYPE NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE
#678Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia
#679BL21 strain lacking a functional group II capsular gene cluster
#680GLP-I Agonist And Cardiovascular Complications
#681Treating diabetes melitus using insulin injections with less than daily injection frequency
#682ADIPONECTIN FOR TREATING PULMONARY DISEASE
#683METASTIN DERIVATIVE AND USE THEREOF
#684Composition for long-acting peptide analogs
#685Modified gherlin peptides
#686Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
#687Non-cytotoxic protein conjugates
#688NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS
#689Compositions and methods for stimulating gastrointestinal motility
#690THERAPEUTIC AGENT AND DETECTION REAGENT FOR ARTERIOSCLEROTIC DISEASE WHICH TARGETS FOR SALUSIN
#691METHODS FOR TREATING RHEUMATOID ARTHRITIS
#692Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
#693Chimeric natriuretic polypeptides with unique pharmacologic profiles
#694DERIVATISED HYBRID PEPTIDES OF AMYLIN AND SALMON CALCITONIN
#695Oxyntomodulin peptide analogue
#696Methods of purifying zsig33
#697Protease resistant modified IFN beta polypeptides and their use in treating diseases
#698DPP-IV resistant GIP hybrid polypeptides with selectable properties
#699Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
#700GAS57 mutant antigens and GAS57 antibodies
#701Ghrelin analogues
#702Amylin derivatives
#703Process for producing hepcidin
#704Stabilisation of Proteins
#705Methods of making an antibody that binds a chemerin polypeptide
#706Albumin fusion proteins
#707Hypoxia induced mitogenic factor
#708PEPTIDE YY ANALOGS
#709Glucose-regulating polypeptides and methods of making and using same
#710NEUROMEDIN U DERIVATIVE
#711METHOD FOR DETERMINATION OF PRESENCE OR ABSENCE OF PEPTIDE COMPOUND PYY3-36
#712HUMAN PANCREATIC POLYPEPTIDE (HPP) ANALOGUES AND THEIR EFFECTS ON FEEDING BEHAVIOUR
#713MODIFIED MINIATURE PROTEINS
#714Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes
#715COMPOSITIONS AND METHODS COMPRISING A LIGAND OF CHEMERINR
#716PEPTIDES DERIVATIZED WITH A-B-C-D- AND THEIR THERAPEUTICAL USE
#717Mirac Proteins
#718Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
#719PROCESS FOR THE PRODUCTION OF PRAMLINTIDE
#720Fusion proteins
#721Modified ghrelin peptides
#722IMPROVED DERIVATIVES OF AMYLIN
#723Process for isolation and purification of a target protein free of prion protein (PrP)
#724Deletion of unwanted reply messages in e-mail printing
#725USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#726Aquaretic and natriuretic polypeptides lacking vasodilatory activity
#727METHODS OF TREATING EPITHELIAL LESIONS OUTSIDE THE STOMACH AND INTESTINES
#728Method for determining MIF content
#729Y-RECEPTOR AGONISTS
#730Polypeptides and polynucleotides encoding same
#731Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
#732Pluripotency determining factors and uses thereof
#733Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
#734Methods of making proteins and peptides containing a single free cysteine
#735ISOLATED MODIFIED HUMAN CHORIONIC GONADOTROPIN PROTEINS
#736Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
#737METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER
#738Lactococcus promoters and uses thereof
#739NEUROMEDIN U RECEPTOR AGONISTS AND USES THEREOF
#740Ghrelin analogs
#741N-terminal derivatisation of proteins with polysaccharides
#742Biosynthetic Polypeptides Utilizing Non-Naturally Encoded Amino Acids
#743Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance
#744Novel polpeptide and use thereof
#745Diagnosis and risk stratification by determining the marker CT-proADM
#746ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#747Peptides directed for diagnosis and treatment of amyloid-associated diseases
#748Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide
#749Derivatisation of erythropoietin (EPO)
#750N-terminal polysialylation
#751Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology
#752Ligand/lytic peptide methods of use
#753Derivatisation of granulocyte colony-stimulating factor
#754Compositions and methods for treating kidney disease
#755Method for determination of presence or absence of peptide compound PYY
#756Methods of identifying modulators of ChemerinR polypeptides
#757Process for Globular Adiponectin Production
#758Compounds and their effects on feeding behaviour
#759Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP)
#760METHOD OF MODIFYING GLUCOSE ACTIVITY USING POLYPEPTIDES SELECTIVELY EXPRESSED IN FAT TISSUE
#761Method of promoting bone growth by an anti-activin B antibody
#762Compositions and methods for stimulating gastrointestinal motility
#763OXYNTOMODULIN ANALOGUES AND THEIR EFFECTS ON FEEDING BEHAVIOUR
#764Hybrid Polypeptides with Selectable Properties
#765Analogs of Gastric Inhibitory Polypeptide as a Treatment for Age Related Decreased Pancreatic Beta Cell Function
#766Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#767Compositions of active Wnt protein
#768METHODS FOR TREATING INFLAMMATION
#769Methods of using motilin homologs
#770GLP-1, exendin-4, peptide analogs and uses thereof
#771Peptides for development of diagnostic and therapeutic agents and methods of using same
#772FGF variants and methods for use thereof
#773TREATING EYE DISORDERS USING INTESTINAL TREFOIL PROTEINS
#774Tissue protective peptides and uses thereof
#775system and uses thereof
#776GLP-I Agonist And Cardiovascular Complications
#777Modified PYY (3-36) peptides and their effects on feeding behavior
#778Compounds and their effects on feeding behaviour
#779Methods of treating using hormone-albumin fusion proteins
#780PYY Agonists and Uses Thereof
#781PYY Agonists and Uses Thereof
#782Modified gherlin peptides
#783Treatment of Diabetes Related Obesity
#784SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID BETA, PRION PROTEIN, AMYLIN, ALPHA-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
#785Non-cytotoxic protein conjugates
#786ZSIG33-like polynucleotides
#787Neuropeptide alarin
#788Protease resistant modified erythropoietin polypeptides
#789Interferon-β mutants with increased anti-proliferative activity
#790Method for identifying HIV-1 protease inhibitors with reduced metabolic affects
#791Activin-ActRIIa antagonists and uses for promoting bone growth
#792Albumin Fusion Proteins
#793Method for promoting bone growth using activin-ActRIIa antagonists
#794Albumin Fusion Proteins
#795Composition for long-acting peptide analogs
#796Methods and compositions for preventing and/or treating pancreatitis
#797Method of forming a peptide-receptor complex with zsig33
#798Genetic variation in pro-melanin-concentrating hormone gene affects carcass traits in cattle
#799Protease resistant modified interferon-beta polypeptides
#800Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)
#801GIP analog and hybrid polypeptides with selectable properties
#802Fusion proteins
#803Labelled adrenomedullin derivatives and their use for imaging and therapy
#804Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
#805ACTIVATABLE CLOSTRIDIAL TOXINS
#806Bifunctional hormone having alpha-MSH activity and natriuretic peptide activity and uses thereof
#807Human Spasmolytic Polypeptide in Glycosylated Form
#808Stabilized bioactive peptides and methods of identification, synthesis, and use
#809Therapeutic uses of factors which inhibit or neutralize MIF activity
#810GIP analog and hybrid polypeptides with selectable properties
#811Modified human four helical bundle polypeptides and their uses
#812High purity peptides
#813Human Spasmolytic Polypeptide in Glycosylated Form
#814Amylin family peptides
#815Protease resistant interferon beta mutants
#816Labelled adrenomedullin derivatives and their use for imaging and therapy
#817Y4 Selective Receptor Agonists For Thereapeutic Interventions
#818Cardioinhibitory/antihypertensive novel endogenous physiologically active peptide
#819Y2 selective receptor agonists for therapeutic interventions
#820Methods and compositions for selective modulation of vascularization
#821Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#822Trefoil Factor 3 (Tff3) as a Target for Anti-Cancer Therapy
#823Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#824Albumin fusion proteins
#825Hepcidin, hepcidin antagonists and methods of use
#826Inhibition of Islet Amyloid Polypeptide (Iapp) Aggregation for the Treatment of Type 2 Diabetes
#827Modified Human Four Helical Bundle Polypeptides and Their Uses
#828Amylin family polypeptide-6 (AFP-6) analogs and methods of making and using them
#829Amphipathic glycopeptides
#830TML polynucleotides
#831Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
#832β-like glycoprotein hormone polypeptide and heterodimer
#833Non-cytotoxic protein conjugates
#834Method for reducing the immune response to a biologically active protein
#835Albumin Fusion Proteins
#836Albumin fusion proteins comprising insulin polypeptides
#837Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
#838Modified human four helical bundle polypeptides and their uses
#839Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes
#840Albumin Fusion Proteins
#841Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
#842G-CSF-albumin fusion proteins
#843Modified Human Four Helical Bundle Polypeptides and Their Uses
#844Albumin fusion proteins
#845Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#846Method for Inducing Mammary Epithelial Cell Differentiation
#847Compositions comprising a ligand of chemerinR
#848Modified Human Interferon Polypeptides and Their Uses
#849Modified Human Interferon Polypeptides and Their Uses
#850Polypeptide Hormone Phosphatonin
#851Modified Human Growth Hormone Polypeptides and Their Uses
#852Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses
#853S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis
#854Modified Human Growth Hormone Polypeptides and Their Uses
#855Modified Human Growth Hormone Polypeptides and Their Uses
#856Modified human four helical bundle polypeptides and their uses
#857Polypeptide hormone phosphatonin
#858Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
#859Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
#860Combination Therapy for the Treatment of Obesity
#861Beta-like glycoprotein hormone polypeptide and heterodimer
#862Stable analogs of peptide and polypeptide therapeutics
#863ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#864Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#865Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
#866Method for identifying HIV-1 protease inhibitors with reduced metabolic affects through detection of human resistin polymorphisms
#867Compositions and methods for treating kidney disease
#868Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#869Substantially pure steroidogenesis inducing peptide and uses thereof
#870Bioactive Compositions, Natural Methods of Producing Them and Computational Methods for Designing Natural Production Processes
#871Isoforms of brain natriuretic peptide
#872Compositions of active Wnt protein
#873Process for the production of preformed conjugates of albumin and a therapeutic agent
#874Albumin fusion proteins
#875Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
#876Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth
#877Neuromedin U receptor agonists and uses thereof
#878Albumin fusion proteins
#879Peptide Yy Analogues
#880INTRANASAL PYY FORMULATIONS WITH IMPROVED TRANSMUCOSAL PHARMACOKINETICS
#881Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
#882Novel Polypeptide Hormone Phosphatonin
#883Antibodies to the polypeptide hormone phosphatonin
#884Protease resistant interferon beta mutants
#885Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
#886Polypeptides and polynucleotides encoding same
#887Prostatic growth factor
#888Production of glycoproteins using manganese
#889Amylin aggregation inhibitors and use thereof
#890Yeast expression vectors for production of ITF
#891Insulin epitopes for the treatment of type 1 diabetes
#892Delivery of trefoil peptides
#893Delivery of trefoil peptides
#894Compositions of active Wnt protein
#895Compositions, methods, and kits relating to resistin
#896Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance
#897GLP-1 agonist and cardiovascular complations
#898Uses of secretagogues like ghrelin in cancer cachexia and for stimulating appetite
#899Long-acting derivatives of pyy agonists
#900Mammalian genes modulated during fasting and feeding